Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Complementary Medicines
Database
Language
Affiliation country
Publication year range
1.
Toxicol Mech Methods ; 28(9): 699-708, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30019977

ABSTRACT

Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra of the midbrain. Dopamine agonists help the patients with PD by reversing the dopamine depletion and related motor deficits. In the present work, cabergoline, a potent ergot dopamine agonist, was given in the form of cabergoline alginate nanocomposite (CANC) to the PD model flies to study its effects on climbing ability, activity pattern, life span, lipid peroxidation, glutathione (GSH) content, glutathione-S-transferase (GST) activity, dopamine content, protein carbonyl content, mean gray-scale values, and caspase-3 and caspase-9 activities. Cabergoline alginate nanocomposite was synthesized by adding the cabergoline solution in the warm aqueous solution of sodium alginate; The synthesized CANC was characterized using fourier transform (FTIR) infrared spectroscopy, transmission electron microscopy (TEM), and UV-Visible spectroscopic techniques. The synthesized CANC having the final doses of 1, 2, and 3 µM was supplemented with diet and the flies were allowed to feed on it for 24 days. Cabergoline alginate nanocomposite significantly increases climbing ability, reduces lipid peroxidation, GST activity, protein carbonyl content, caspase 3/9 activity, mean gray-scale values, and increases the GSH as well as dopamine content in a dose-dependent manner. The results of this study suggest that CANC is potent in delaying and reducing the symptoms of PD.


Subject(s)
Animals, Genetically Modified , Cabergoline/therapeutic use , Dopamine Agonists/therapeutic use , Drosophila melanogaster , Nanocomposites/chemistry , Parkinson Disease/drug therapy , Alginates/chemistry , Animals , Behavior, Animal/drug effects , Cabergoline/chemistry , Disease Models, Animal , Dopamine/metabolism , Dopamine Agonists/chemistry , Dose-Response Relationship, Drug , Drosophila melanogaster/genetics , Longevity/drug effects , Oxidative Stress/drug effects , Parkinson Disease/metabolism , alpha-Synuclein/genetics
2.
Article in English | MEDLINE | ID: mdl-28386534

ABSTRACT

Honey is an excellent source of polyphenolic compounds that are effective in attenuating quorum sensing (QS), a chemical process of cell-to-cell communication system used by the opportunistic pathogen Pseudomonas aeruginosa to regulate virulence and biofilm formation. However, lower water solubility and inadequate bioavailability remains major concerns of these therapeutic polyphenols. Its therapeutic index can be improved by using nano-carrier systems to target QS signaling potently. In the present study, we fabricated a unique drug delivery system comprising selenium nanoparticles (SeNPs; non-viral vectors) and polyphenols of honey (HP) for enhancement of anti-QS activity of HP against P. aeruginosa PAO1. The developed selenium nano-scaffold showed superior anti-QS activity, anti-biofilm efficacy, and anti-virulence potential in both in-vitro and in-vivo over its individual components, SeNPs and HP. LasR is inhibited by selenium nano-scaffold in-vitro. Using computational molecular docking studies, we have also demonstrated that the anti-virulence activity of selenium nano-scaffold is reliant on molecular binding that occurs between HP and the QS receptor LasR through hydrogen bonding and hydrophobic interactions. Our preliminary investigations with selenium-based nano-carriers hold significant promise to improve anti-virulence effectiveness of phytochemicals by enhancing effective intracellular delivery.


Subject(s)
Biofilms/drug effects , Honey , Nanocomposites , Phytochemicals/chemistry , Phytochemicals/pharmacology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/physiology , Quorum Sensing/drug effects , Selenium , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Mice , Microbial Sensitivity Tests , Models, Molecular , Molecular Conformation , Nanocomposites/chemistry , Nanocomposites/ultrastructure , Polyphenols/chemistry , Polyphenols/pharmacology , Protein Binding , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Trans-Activators/chemistry , Trans-Activators/metabolism , Virulence/drug effects
3.
Antimicrob Agents Chemother ; 59(4): 2153-68, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25645848

ABSTRACT

Quorum sensing (QS) regulates group behaviors of Candida albicans such as biofilm, hyphal growth, and virulence factors. The sesquiterpene alcohol farnesol, a QS molecule produced by C. albicans, is known to regulate the expression of virulence weapons of this fungus. Fluconazole (FCZ) is a broad-spectrum antifungal drug that is used for the treatment of C. albicans infections. While FCZ can be cytotoxic at high concentrations, our results show that at much lower concentrations, quercetin (QC), a dietary flavonoid isolated from an edible lichen (Usnea longissima), can be implemented as a sensitizing agent for FCZ-resistant C. albicans NBC099, enhancing the efficacy of FCZ. QC enhanced FCZ-mediated cell killing of NBC099 and also induced cell death. These experiments indicated that the combined application of both drugs was FCZ dose dependent rather than QC dose dependent. In addition, we found that QC strongly suppressed the production of virulence weapons-biofilm formation, hyphal development, phospholipase, proteinase, esterase, and hemolytic activity. Treatment with QC also increased FCZ-mediated cell death in NBC099 biofilms. Interestingly, we also found that QC enhances the anticandidal activity of FCZ by inducing apoptotic cell death. We have also established that this sensitization is reliant on the farnesol response generated by QC. Molecular docking studies also support this conclusion and suggest that QC can form hydrogen bonds with Gln969, Thr1105, Ser1108, Arg1109, Asn1110, and Gly1061 in the ATP binding pocket of adenylate cyclase. Thus, this QS-mediated combined sensitizer (QC)-anticandidal agent (FCZ) strategy may be a novel way to enhance the efficacy of FCZ-based therapy of C. albicans infections.


Subject(s)
Antifungal Agents/pharmacology , Antioxidants/pharmacology , Apoptosis/drug effects , Candida albicans/drug effects , Drug Resistance, Fungal/drug effects , Fluconazole/pharmacology , Quercetin/pharmacology , Quorum Sensing/drug effects , Biofilms/drug effects , Hyphae/drug effects , Microbial Sensitivity Tests , Usnea/chemistry , Virulence Factors/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL